Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The parathyroid hormone 2 receptor (PTH2R) is a member of the class B (type II) G protein-coupled receptor (GPCR) family. The primary endogenous ligand for PTH2R is tuberoinfundibular peptide of 39 residues (TIP39). Human PTH can activate human PTH2R but not rodent orthologs. PTH2R is highly expressed in specific regions of the brain and in the pancreas. It is involved in neuroendocrine regulation, modulates stress response, nociception, calcium transport, and wound healing. It is coupled primarily to Gs proteins, activating adenylyl cyclase, which increases cAMP.
Agonist: Activates adenylyl cyclase, increases cAMP. Antagonist: Blocks receptor activation by TIP39.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parathyroid Hormone 2 Receptor (None).